Shanghai Beyotime Biotechnology Co., Ltd.

Beyotime was founded in 2001 by Chinese scholars who worked and studied at Harvard University. For over 20 years, it has focused on independent R&D and production. In 2007, Shanghai Beyotime Biotechnology Co., Ltd. was established, and it has been recognized as a 'Specialized, Refined, Distinctive, and Innovative' 'Little Giant' enterprise, further selected for the recommended list of such enterprises. It was also selected as one of the third batch of Shanghai's innovative enterprise headquarters, with Mayor Gong Zheng personally presenting the award to Beyotime. Beyotime is also a Shanghai Science and Technology Little Giant enterprise, a G60 Science and Technology Innovation Corridor 'key enterprise', ranked among the Top 100 in the G60 Science and Technology Innovation Corridor's Innovation-Driven enterprises, listed in the 'Top 100 Enterprises' on the Shanghai Specialized, Refined, Distinctive, and Innovative 'Little Giant' Enterprise Brand Value List, honored as a Shanghai Brand Cultivation Benchmark Enterprise, recognized as a Shanghai Specialized, Refined, Distinctive, and Innovative Small and Medium-sized Enterprise, and a Shanghai High-tech Enterprise. Additionally, it serves as a standing director unit of the China Inspection and Testing Society and a director unit of its Scientific Research Reagents Branch. The company primarily develops and produces reagents, kits, consumables, and instrumentation for biological and medical research, while also providing technical services for life science research and a one-stop procurement platform for scientific research equipment. The company boasts 5 national-level talents and over 40 provincial and ministerial-level talents. Its core team comprises high-level researchers from renowned universities and research institutions such as Harvard University, NIH, the University of Hong Kong, and the Chinese Academy of Sciences, as well as managers from top pharmaceutical companies like Novartis. As of the end of 2025, over 300,000 research papers citing the use of Beyotime products have been published in internationally renowned academic journals, including Cell, Nature, and Science. The Beyotime brand achieved a leading literature citation rate in 2025, ranking among the global top 20. Beyotime will continue to dedicate itself to R&D in scientific research technologies and products, leveraging our advanced technologies, mature products, and enthusiastic service to serve life sciences and enhance human health.